chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tired and spacey; Chills; felt light headed; thirsty; headache; back ache; fever; nausea; vomiting; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er2613) via an unspecified route of administration in the left arm on 26Mar2021 at 11:45 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergy. Concomitant medications included trazodone (MANUFACTURER UNKNOWN) , calcium carbonate (CALTRATE), ascorbic acid, tocopheryl acetate, zinc oxide, cupric oxide, betacarotene (PRESERVISION) and diphenhydramine hydrochloride (BENADRYL) from started on unknown date for unspecified indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6203) via an unspecified route of administration in the left arm on 05Mar2021 at 14:45 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. On 27Mar2021 at 01:00, the patient experienced chills, started in the middle of the night, felt light headed and really thirsty when she got up. Then at about noon on 27Mar2021, she had a really bad headache, back ache, fever nausea and vomiting that lasted until morning. The next day on 28Mar2021, the patient, was tired and spacey. On third day the patient felt more like herself, but tired. On fourth day she felt great and back to happy normal self. The patient did not receive any treatment. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event headache, back ache, fever, nausea, vomiting, chills, felt light headed, thirsty and tired was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
10 minutes post vax the pt experienced dizziness, shortness of breath, irregular pulse and malaise. The malaise lasted two days. The pt was treated with Benadryl. Engerix B was discontinued. The most recent information received reports the condition of the pt is resolved.
Vaccine was expired on 02-Apr-2022 and patient administered on 08-Apr-2022; Vaccine administered to 45 patients past 30-day use by date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered to 45 patients past 30-day use by date) and PRODUCT STORAGE ERROR (Vaccine was expired on 02-Apr-2022 and patient administered on 08-Apr-2022) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 068H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered to 45 patients past 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 02-Apr-2022 and patient administered on 08-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered to 45 patients past 30-day use by date) and PRODUCT STORAGE ERROR (Vaccine was expired on 02-Apr-2022 and patient administered on 08-Apr-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The BUD date was reported as 02-Apr-2022. All 45 patients were adults, who received the Moderna vaccine beyond the 30-day use by date and no additional information was provided. Date Stored in Standard Freezer for the lot 068H21A was 2 degrees F (high), -1 degrees F (low) on 04-Jan-2022. No treatment information was provided.
606 doses were given after expiration date; Vaccine stored in refrigerator on 10/26/2021, expired product 10/13/2021, administered date on 10/28/2021; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 10/26/2021, expired product 10/13/2021, administered date on 10/28/2021) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 10/26/2021, expired product 10/13/2021, administered date on 10/28/2021). On 28-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 10/26/2021, expired product 10/13/2021, administered date on 10/28/2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  It was reported that the vaccine was stored in refrigerator on 26-Oct-2021, there was no temperature excursion and The patient did not experience any adverse event.  No treatment medications were provided.
Fever 102. - 101, Chills for about 12 hours, bed rest for 24 hrs took Tylenol every four hours and fluids.  The Vaccine site is red, swollen and hot size of an orange.  After 12 hours fever broke, exhausted for additional 12 hrs.  No symptoms 12/22 or 12/23/2020
EXTREME FATIGUE, CHILLS, WEAKNESS, NAUSEA, BODY ACHES, CONFUSION, FAINT.
Swelling and pain in calf; Pain in calf; Joint pain; This is a spontaneous report from a contactable healthcare professional. A 35-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 13Jun2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Other medical history reported as none. The patient had no known allergies to medications, food and other products. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Concomitant medications were not reported. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. On 15Jun2021, the patient experienced swelling and pain in calf and joint pain. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events swelling and pain in calf and joint pain was not recovered at the time of this report.  The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.
This spontaneous report as received from a consumer refers to an infant of unknown age. In 2012 the infant was vaccinated with a dose of RECOMBIVAX HB (lot # reported as 0809Y, expiration date unspecified). Concomitant therapies included oral ROTATEQ (lot # 664076/0768Y, expiration date 26-JAN-2011). The consumer inquired into the expiration dates for RECOMBIVAX lot 0809Y, expiration date unspecified, and ROTATEQ lot 0768Y expiration date unspecified. She stated that they were "administered to an infant in 2010" and now the consumer was concerned that they were expired (in fact, the oral ROTATEQ was not expired; expiration date was 26-JAN-2011). The consumer stated "I don't feel comfortable discussing it, but I am concerned that they were expired at the time," and "I don't want to jump the gun until I know if they were expired or not." At the time of the report, the outcome of the event was unknown. Additional information is not expected.
I developed iron deficiency anemia on 14FEB2023, I was out of breath and headaches. I was very tired all the time while walking, I normally would walk about 5 miles a day but it I couldn't. I also had restless feet. I didn't know what was going on, I went to a foot doctor and I had no results. Than I went to another doctor and he did a blood test and found out I had severe iron deficiency.
On 8/14/2012 presented with cough x1 month worse in AM. Put on ZPACK. Came back 8/20/12 continued symptoms. Chest xray (-) pertussis PCR (-) sib diagnosed with pertussis at same time. Suspected pertussis.
Patient reports having been recently diagnosed with kidney failure. Patient believes the symptoms were adverse reactions of her recent Pfizer Covid 19 shot given 9/19/22. Patient wanted to get Pfizer on 9/19 even though her all previous covid-shots were Moderna. Before shots were given, every questionnaire was checked: no allergies or chronic conditions; patient answered all 'no' for any precautions and contraindications; checked eligibility; last booster was 4/6/22; Patient got both flu-shot and Pfizer shot at the same visit as patient wanted. All possible common side effects were counseled and asked patient to stay near the pharmacy for 15 min to make sure if patient has no reactions. On 10/17/22, Patient visited pharmacy to report her recent symptoms; reports that she had no energy for the next few days after the two shots. Due to continuous fatigue and malaise, patient went to see her primary doctor and was diagnosed with kidney failure recently.
psoriasis covered entire scalp, lower back, 30% of face,  elbows and hands and patches on legs. / psoriasis appeared inside nose and ears. Partially covered eyelids; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Sep2021 (Lot number: FD0809) at the age of 61 years as dose 3 (booster), single and administered in arm right, administration date 01May2021 (Lot number: EW0179) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing); "Hypothyroidism" (unspecified if ongoing); "High Cholesterol" (unspecified if ongoing); "Had Plaque Psoriasis For 40 Years" (unspecified if ongoing). Concomitant medication(s) included: ROSUVASTIN; AMLODIPINE; LEVOTHYROXINE. Past drug history included: Losartin, reaction(s): "Known allergies: losartin"; Benazepril, reaction(s): "Known allergies: benezepril". Vaccination history included: Bnt162b2 (Prev Dose Product: COVID 19,, Prev Dose Brand: Pfizer,, Prev Dose Brand Unknown: False,, Prev Dose Lot Number: EW0162,, Prev Dose Lot Unknown: False,, Prev Dose Administration Date: 10Apr2021,,  Prev Dose Dose Number: 1,, Prev Dose Vaccine Location: Left Arm), administration date: 10Apr2021, when the patient was 60 years old, for COVID-19 Immunization. The following information was reported: PSORIASIS (non-serious) with onset 04May2021, outcome "recovering", described as "psoriasis covered entire scalp, lower back, 30% of face,  elbows and hands and patches on legs. / psoriasis appeared inside nose and ears. Partially covered eyelids". The event "psoriasis covered entire scalp, lower back, 30% of face,  elbows and hands and patches on legs. / psoriasis appeared inside nose and ears. partially covered eyelids" was evaluated at the physician office visit. Therapeutic measures were taken as a result of psoriasis.  Additional information: Facility Type Vaccine was Doctor's Office/Urgent Care. No other vaccine in four weeks. Other Medications In Two Weeks was Rosuvastin, Amlodipine, Levothyroxine, Hydrochlori. She had plaque psoriasis for 40 years. Never had it anywhere else but back of scalp. After 2nd pfizer does, 3 days later psoriasis covered entire scalp,lower back, 30% of face, elbows and hands and patches on legs. After boosters (3rd) dose, psoriasis appeared inside nose and ears. Partially covered eyelids. Still not resolved as of 09mar after being on tremfya for 6 months. Currently on skirizi and cyclosporin. Adverse event resulted in doctor or other healthcare professional office/clinic visit. Treatment received for AE which included laser, estilar, tremfy, skyrizi and cyclosporine . No covid prior vaccination. Not tested for covid for post vaccination.  No follow-up attempts are possible. No further information is expected.
Right away she did have a headache and was fatigued. The next day she seemed pretty normal. On 07/13/2022 She did come down with fatigue, a headache, low grade fever, and overall tiredness. We took her to her pediatrician the same day, they did evaluate for strep, flu, and COVID-19 and all tests came back negative. As of today she is doing completely fine and is back to her normal self.
After 10 minutes I felt nauseous, warm and my vision went black and white. I was on the verge of fainting. I laid down for another 10 minutes while drinking water and I felt much better. Have general malaise for 4 hours now since the shot, but that seems standard. I was surprised I felt the effects  right away.
This spontaneous report was received from a pharmacist, refers to a 26 year-old patient of an unknown gender. The patient's medical histroy, concurrent conditions and concomitant therapies were not provided.     In approximately 2007 (reported as "when the patient was 16 year-old"), the patient was vaccinated with the 3 dose series of GARDASIL injection (strength, dose schedule, route, lot# and expiration date were not provided) for prophylaxis. It was reported that on 18-MAY-2017 (reported as "2 weeks ago at the age of 26 year-old"), the patient was vaccinated with GARDASIL 9 injection (strength, dose schedule, route, lot# and expiration date were not provided) for prophylaxis. No adverse effects were reported. Additional information has been requested.
Temp. 102, chills, body aches, headache, extreme fatigue; slept most of the day on the 1st; still w/body aches, less fatigue, decreased headache, temp 100 on  01/02; back to normal by 2:00 on 01/02
Fever, irritability, not feeling good 2/12 PM. Fever increased (2/13-2/14) to 103-104 degrees with sore throat, difficulty in swallowing, nausea, weakness, lethargy. This continued for a week. Other symptoms (resulting in diagnosis) followed. Called doctor's office; was told to bring him in because it was probably flu. The medical record states dysphagia. 60 day follow up on 11/06/2003: "Vaccine recipient did not recover from adverse event.  Ongoing illness include: juvenile rheumatoid arthritis, Raynaud's, scleraderma, dermatamyositis."
Swelling under armpits; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swelling under armpits) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Swelling under armpits). At the time of the report, LYMPHADENOPATHY (Swelling under armpits) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.
I was a little achy about 7 hours after I got my second vaccine. Later that evening, it hurt to raise the arm where I received the injection. The next day, about 24 hours after the vaccine, I had a fever of 100.1° and my arm was tight, red, and warm to the touch around the injection site. My fever broke by 29 hours after the injection, but my arm is still warm, tight, and red 50 hours after the vaccine.
Pt here today for her second dose of Moderna COVID vaccine. States she did not have any issues with her first dose. Pt does endorse hx of syncope.    Approximately 10 minutes after pt received vaccine, she started to feel dizzy and faint and was slouched over in her chair. Pt pale, flushed, tangibly warm and sweaty skin. Transferred pt to stretcher. Pt endorses that she did have breakfast this morning. Felt slightly nervous about getting the vaccine but not overly anxious.    Vitals taken: BP 95/59, HR 75, O2 99%. Rapid response called. Rapid response nurse arrived at bedside.    Repeat vitals, taken approximately 5 minutes apart:  BP 109/63, HR 96, O2 99% BP 109/63, HR 97, O2 99% BP 114/77, HR 108, O2 99% BP 101/70, HR 99, O2 100% BP 106/62, HR 97, O2 100%   Pt given juice with some improvement in symptoms. Started to feel her hands tingling and had sensation of cold flowing through her body. Feelings of dizziness waxed and waned.    Pt transported to ED by rapid response team for further observation.  ED MD notes: "MDM, ASSESSMENT AND PLAN:  Overall well-appearing 39 year female experiencing lightheadedness after vaccination.  She has no other signs or symptoms to suggest an acute allergic reaction.  This may be vasovagal.  Plan for urine pregnancy test and EKG, consider IV fluids.  Patient prefers not to undergo testing unless completely necessary.  We decided to obtained orthostatic vital signs and if patient is symptomatic and/or showing significant changes in blood pressure or pulse with positional change, then will proceed with limited workup for near syncope.   DIAGNOSTIC STUDIES O2 sat interpretation: normal on RA Equivocal orthostats - HR incr w/ standing but so did BP. Pt states she's feeling better, tolerating po. Again denies poss pregnancy. Prefers to go home. OK to dc, close return precautions.     IMPRESSION: Dizziness. Adverse medication (vaccination) reaction, not allergy."
Individual completed the 2 dose series of Moderna COVID-19 vaccine on 2/3/2021.  Was exposed to COVID-19 on 2/27/2021. Became symptomatic with COVID signs/symptoms on 3/1/21 and tested positive by rapid antigen on 3/1/21.
A reoccurrence of pancreatitis. In this event there was necrotizing that resulted in an approximate loss of 50% of the pancreas. Lipase levels were highly elevated >1200. Release after 6 days of hospitalization. Had a reoccurring bout requiring hospitalization starting on December 12. Taken to the hospital again after a slight fever of 99.3 on the 13th admitted to the hospital for an additional two days.
This case was reported by a lawyer and described the occurrence of suspected shaken baby syndrome in an infant subject of unspecified gender who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis absorbed, hepatitis B recombinant and inactivated poliovirus vaccine combined (Pediarix) for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified dose of Pediarix (unknown, lot number not provided). Six days after vaccination with Pediarix, the subject experienced suspected shaken baby syndrome and an unspecified adverse event. The reporter stated that the defendant, who is being prosecuted for shaken baby, "claims that the infant crashed because of an adverse reaction to Pediarix, rather than due to being shaken." The infant was treated in the emergency room. Treatment was not specified. The reporter stated that "the emergency room doctors were said not to have attributed to the event(s) to the Pediarix." At the time of reporting the outcome of the events was unspecified. No further information was provided. This was considered medically serious (OMIC) by manufacturer.
Initial report was received on 22 December 2010 from a health care provider which involved a case of misuse. An 11 year-old male patient who had no illnesses at the time of vaccination, had received on 21 December 2010 an expired intramuscular right deltoid first dose injection of MENACTRA, lot number U3068AA (expiration date 03 November 2010) and an intramuscular right deltoid injection of ADACEL, lot number U3049CA (sanofi pasteur Ltd. lot number C3258) and at 0200 (2AM) on 22 December 2010, he experienced a fever of 102.4. The patient was treated with TYLENOL and at 0400 (4AM) on 22 December 2010 his fever was 99-100 F. He then experienced a five to seven minute episode of uncontrollable muscle twitching of his arms, a feeling like his head was "going to pop off' and he had blurry vision. The reporter stated the patient was "okay" and his temperature was normal however he had an "upset stomach". No further information was available at the time of the report. Documents held by sender: none.
received vaccine at 2:07 pm  and was sitting in clinic lobby, as instructed, with her father.   at 2:15 pm father came in and informed me that  was not feeling well, I went out to check on her and she was laying on the arm of her chair , eyes open, looking pale.  I and her father , walked her back to the clinic and had her lay down on exam table, bp 88/60 pulse : 72.  she laid on exam table for about 20 minutes, we gradually sat her up she was able to sit upright and walk in exam room with no problems, bp at 2:30 =98/60 , hr = 88 bpm.  She was walking around and standing with no difficulty, she left with her father.
This was my booster.  I received my first two pfizer shots in Feb. 2021, after which I developed tinnitus, but did not connect the tinnitus to the injections (onset was either not immediate or I was simply too dismissive of the idea, being pro-vaccine in mindset).  During the course of 2021, the tinnitus remained, but became more manageable.  So when I woke up early in the morning on the day after my booster, with my ears ringing much louder than ever, the connection to the shot seemed unmistakable and undeniable.
volume of 1 mL was administered; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL OVERDOSE (volume of 1 mL was administered) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced ACCIDENTAL OVERDOSE (volume of 1 mL was administered). On 21-May-2021, ACCIDENTAL OVERDOSE (volume of 1 mL was administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were not provided. No treatment medications were not provided.   This case was linked to MOD-2021-250762, MOD-2021-162399, MOD-2021-250948 (Patient Link).
Pt recvd 3 doses of Engerix-B on 23JAN91, 20FEB91, & 10JUL91 & 9OCT91 post HBSAB was 7.2RU which indicates low titer, immune status questionable;
Over a couple of weeks, I developed progressively worse nasal congestion which resulted in some difficulty breathing exacerbated by lying down. I also had loss of sleep, blood clots in the tissue after blowing your nose. I had intermittent nose pain and tiredness. On the last day prior to going to the doctor I had mild confusion. I went to the doctor believed that my anxiety was exacerbated back lack of sleep and not being able to breath through the nose. I was diagnosed with allergic rhinitis and prescribed. I was prescribed Zyrtec and Fluticasone Propionate Flonase. I was able to sleep that night and it was better by the next morning.  I am still continuing to have some congestion and I am still continuing to take the medication.
Severe soreness and pain at injection site. So painfull cannot raise rt. arm (arm of injection site).
Very heavy Chest, broke out in hives all over body. Especially on fingers, chest and thighs. Hives lasted 6 weeks